In the war for GLP-1 patients, Novo Nordisk leans on telehealth

What's new in pharma

May 23, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | In the war for GLP-1 patients, Novo Nordisk leans on telehealth Telehealth companies Ro and LifeMD are promoting Novo Nordisk's weight loss drug Wegovy at a discount, marking a new chapter in GLP-1 wars. By Katie Palmer FDA gives Covid vaccine manufacturers instructions for next fall's shot The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to update their vaccines. By Helen Branswell Opinion: To address the pharmacy crisis, doctors should dispense some drugs Point-of-care drug dispensing could ease pressures on pharmacists while improving patient medication access. By Patrick Aguilar and Matt Hoff Allen Lab/NCI/NIH STAT+ | Merus drug, with immunotherapy, shows preliminary survival boost for patients with head and neck cancer In a mid-stage trial, 79% of patients with newly diagnosed metastatic head and neck cancer lived for at least one year By Adam Feuerstein STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser